Prospective Survey of Menstrual Migraine & Prevention With Eletriptan

PHASE4CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

August 31, 2008

Conditions
Migraine
Interventions
DRUG

eletriptan

oral eletriptan 20 mg three times a day beginning 2 days before the expected onset of menstrual flow and continued for a total of 6 days

Trial Locations (1)

15206

University of Pittsburgh, Pittsburgh

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Pittsburgh

OTHER

NCT00259649 - Prospective Survey of Menstrual Migraine & Prevention With Eletriptan | Biotech Hunter | Biotech Hunter